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ABSTRACT
This report refers to a body of investigations performed in support of
experiments aboard the Space Shuttle, and designed to counteract the symptoms
of Space Adapatation Syndrome, which resemble those of motion sickness
on Earth. For these supporting studies we examined the autonomic
manifestations of earth-based motion sickness. Heart rate, respiration rate,
finger pulse volume and basal skin resistance were measured on 127 men and
women before, during and after exposure to nauseogenic rotating chair tests.
Significant changes in all autonomic responses were observed across the tests
(p<.05). Significant differences in autonomic responses among groups divided
according to motion sickness susceptibility were also observed (p<.05).
Results suggest that the examination of autonomic responses as an objective
indicator of motion sickness malaise is warranted and may contribute to the
overall understanding of the syndrome on Earth and in Space.
DESCRIPTORS: heart rate, respiration rate, finger pulse volume, skin
resistance, biofeedback, motion sickness.
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General Autonomic Components of Motion Sickness
Patricia S. Cowings, Steven Suter, William B. Toscano,
Joe Kamiya, and Karen H. Naifeh
Motion sickness is a pervasive feature of hunan travel. Unfortunately,
the practical understanding of this unpleasant condition is very limited. With
the advent of manned space flight there is a genuinely urgent need to
understand and control motion sickness, since approximately 50% of the first
human space travellers have suffered from "space adaptation syndrome" (SAS)—
the zero gravity analogue of ordinary terrestrial motion sickness. The SAS is
a particularly troublesome problem because traditional treatments, such as
anti-motion sickness drugs, have had limited value in preventing or aborting
in-flight symptoms, and at present there are no reliable ground-based tests
for predicting susceptibility in space. Furthermore, deleterious side-effects
of various drugs have been noted which could potentially interfere with crew
performance (Wood, Graybiel & Kennedy, 1966; Wood & Graybiel, 1968; Homick,
Kohl, Reschke, Degioanni, & Cintron-Trevino, 1983).
We cannot, on the surface of a planet, simulate the unique stimulation to
the vestibular system (inner ear) which occurs in a weightless environment
(except for brief periods during parabolic flight). But using a variety of
ground-based tests, we can induce the symptoms of motion sickness. Laboratory
procedures that are used to study motion sickness, (e.g., rotating chairs,
Vertical accelerators and optokinetic stimuli) provide an excellent means of
investigating those mechanisms involved in responses to unusual gravito-
inertial environments. As reviewed by Reason & Brand (1975), several
early investigations have established the importance of the vestibular system
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as the principal sensory receptors for motion sickness. The most influential
theories on the etioligy of motion sickness have been couched in terms of
vestibular physiology, related central nervous system (CNS) pathways and
centers/ and sensory conflicts or "mismatches" between afferent channels
(Kohl, 1983). While this work has clarified certain aspects of motion
sickness, it does not fully describe the mechanisms involved in the etiology
of this disorder, nor has it yielded a viable treatment.
Since 1974, our research group at NASA Ames Research Center has been
studying terrestial motion sickness and thinking about the SAS from a
different perspective. The focus of our investigations has been autonomic
nervous system (ANS) responses to stimulation rather than central nervous
system (CNS) mechanisms involved in the etiology of this syndrome. Our method
of treatment involves training in physiological self-regulation as an
alternative to pharmacological management. The treatment method,
Autogenic-Feedback Training (AFT), combines two techniques that have been used
widely to facilitate self-regulation of involuntary ANS responses and minimize
the debilitating effects of various stressors. Autogenic Therapy (Schultz
& Luthe, 1969) uses self-suggestions (e.g., "My arms are heavy.") to
encourage beneficial psychophysiological changes, while biofeedback
employs an exteroceptive feedback signal to facilitate voluntary control over
ANS responses that are frequently dysregulated by stress. The rationale for
using AFT to combat motion sickness and SAS was based on the following
assumptions: (a) there are profound ANS changes associated with these
disorders, and (b) learned self-regulation of the participating ANS response
systems will enable a person to successfully resist the debilitating effects
of nauseogenic stimulation. Consistent with these assumptions, a series of
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studies have shown that AFT significantly increases the time that trained
individuals can tolerate motion sickness stimulation, as compared to control
subjects who received no AFT (Cowings, Billingham & Toscano, 1976; Oowings &
Toscano, 1982; Cowings & Malmstrom, 1984; Toscano & Cowings 1978; Toscano &
Cowings, 1982; Levey, Jones & Carlson, 1981; Stewart, Clark, Cowings &
Toscano, 1978). This observed increase in motion sickness tolerance supports
the notion that the treatment effect is due to learned self-regulation of ANS
activity.
Necessarily, our research group has devoted a great deal of time to
gaining a better clinical understanding of hunan autonomic manifestations of
motion sickness. To apply AFT, an individual's ANS responses to motion stimuli
are first documented, and emphasis is placed on training the individual to
gain control of those variables that diverged the most from his or her own
resting levels. The very fact that AFT does reduce the severity of
symptoms experienced points out the need to examine more systematically the
relationship between autonomic activity levels and motion sickness malaise.
The relative importance of ANS responses in understanding and treating
motion sickness has been a matter of some controversy. There are several
published articles which deny the usefulness of examining ANS activity at all.
Money (1970), in his lengthy review of motion sickness research, discussed
many possible ANS changes during motion sickness, but correctly noted that
there was little consistency in either procedures used or results of the
"available research. He then rather pointedly argued against the importance of
the.ANS in motion sickness: "...to the extent that motion sickness is nausea
and vomiting, it is not an autonomic phenomenon and it cannot be considered a
development of the autonomic nervous system."
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Graybiel and Lackner (1980) have also minimized the role of the ANS in
motion sickness. They subjected 12 college students to an unusual
"sudden-stop" vestibular/visual test designed to induce motion sickness
symptoms. Measures of heart rate, body temperature and blood pressure were
taken prior to and following, but not during, repeated (30 second) test
exposures. They found these measures to be remarkably invariant from pretest
baseline throughout the onset of nausea which was the end point for each test
sequence! They concluded that "Such measures, therefore, appear to have
little value in assessing or diagnosing severity of motion sickness. This lack
of correlation means that use of physiological training procedures to control
these variables is likely to be of little value in preventing symptoms of
motion sickness" (Graybiel & Lackner, 1980, p. 214).
Those investigators who do believe that ANS activity may yield
valuable information on the motion sickness syndrome are divided in
their interpretation of the ANS mechanisms involved. Tang & Gernandt (1969)
demonstrated various ANS responses to electrical stimulation of the vestibular
apparatus in cats, and concluded that "... all common symptoms of motion
sickness, probably have their genesis in the strong responses of the
sympathetic system to vestibular stimulation." Consistent with the hypothesis
of Tang and Gernandt (1978), Parker (1964, 1971), and Parker, Schaeffer &
Cohen (1972) developed a practical psychophysiological test for motion
sickness susceptibility. They classed individuals as susceptible or
nonsusceptible to motion sickness stimulation based on the amplitude of their
electrodermal responses to a film depicting a ride down rough, twisting
mountain roads in a speeding, open sports car. When tested later on the open
sea on a sailing vessel, all of the 10 susceptibles either vomited or reported
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severe nausea, while none of the nonsusceptibles showed or reported any signs
of motion sickness.
In contrast, Kohl & Homick (1983) have emphasized the contribution of
cholinergic descending limbic pathways as a modulatory mechanism by which a
sensory conflict may result in actual sickness. These authors stress that the
beneficial results produced by anti-motion sickness drugs are due to the
action of parasympatholytics and/or sympathomimetics.
There are two major purposes of this paper: First, we wish to describe
general ANS changes during motion sickness stimulation, as well as before
and after, since this has not been done heretofore, and to utilize a large
sample of people. Second, since our motion sickness treatment method involves
modifying ANS responses to motion sickness stimulation, we wish to examine ANS
responding as a function of naturally-occurring differences in susceptibility
to motion sickness stimulation, to determine whether there are consistent ANS
response characteristics of high- and low-susceptible individuals. The general
question of individual differences in ANS response during motion sickness
stimulation, including individually sterotyped ANS patterns, will be
considered in detail in another paper. We have used the ANS variables of heart
rate, respiration rate, finger pulse volume and basal skin resistance because
they are easily measured, represent different aspects of the ANS, and have
been used in previous studies of motion sickness.
Method
Subjects.
The data from 127 people, (101 males and 26 females, 18 to 46 years of
age) are described in this paper. On the basis of the total number of minutes
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tolerated during their first motion sickness inducing test, subjects were
categorized as either high (N=46), moderate (N=43) or low (N=38) susceptibles.
All subjects were certified to be in good health and to have normal vestibular
function on the basis of a medical examination. Subjects were paid and were
assured a minimum of 2 hours pay per visit.
Apparatus.
A Stille-Werner rotating chair was used to provoke the initial symptoms of
motion sickness. Padded head rests were mounted at 45 degree angles from the
vertical on the left, right, front, and back of the chair, enabling subjects
to execute standardized head movements in these directions.
The physiological responses measured were (a) electrocardiogram (ECG)
derived from precordial placement of silver/silver chloride disposable
electrodes, with heart rate (HR) computed beat-to-beat and processed with a
Gould Biotachometer; (b) respiration derived through a nose clip thermistor,
with respiratory rate (RR) computed breath-to-breath using a Gould
Biotachometer; (c) blood volume pulse (FV) of the hand, derived from a
photoplethysmograph transducer placed on the right index finger; and (d) basal
skin resistance (BSR) derived from silver/silver chloride electrodes placed on
the index and middle fingers of the left hand.
Biomedical amplifiers were mounted on the rear and sides of the chair,
and the physiological signals were sent to recorders through slip rings. These
biological data were recorded simultaneously on strip charts and on 14-track
magnetic tape; they were digitized on-line using a Nicolet Med-80 signal
processor and were analyzed off-line using a DEC PDP 11/34 computer.
Procedure.
Rotating chair tests. The motion sickness test was a modification of
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a widely used procedure to create Coriolis stimulation by combining head
movements out of the vertical axis with body rotation (Miller & Graybiel,
1970). The blindfolded participant sat in a Stille-Werner rotating chair in a
sound-shielded experimental chamber. Following a resting baseline period of
either 5 or 10 minutes (depending on the experiment), rotation was initiated
at 6 rpm (0.628 rad/sec) and incremented by 2 rpm (0.209 rad/sec) every 5
minutes. The rotational velocity during each 5-min interval was held constant.
The maximum velocity was 30 rpm (3.142 rad/sec). At 2-sec intervals throughout
each 5-min interval, head movements at 45 degree angles from the vertical were
executed in four directions (left, right, forward, and backward), the
direction randomized and signaled via tape-recorded running voice instruction.
At the end of the 5-min interval, the head movements ceased for 30 seconds,
but rotation continued, while a standard diagnostic motion sickness scale was
administered (Graybiel, Wood, Miller, & Cramer, 1968). This scale was also
administered upon the termination of tests.
Each participant was instructed in advance to ride as long as he or she
could, short of vomiting. The test was terminated when either: (a) the
participant requested termination, (b) the diagnostic scale indicated
sufficient symptoms so that the experimenter judged it unwise to continue, or
• i
(c) vomiting occurred (which rarely happened).
Diagnostic scale. The diagnostic scale, referred to as the Coriolis
Sickness Susceptibility Index (CSSI), was developed as a means to obtain
standardized reports of the level of malaise that an individual is
experiencing at any given time in a motion sickness eliciting test. This
instrument is based on self-report and experimenter observations with respect
to vomiting, subjective body temperature, dizziness, neadache, drowsiness,
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sweating, pallor, salivation, and nausea. A single global motion sickness
score for a given test period can be derived using a complex scoring and
weighting system (see Table 1).
Table 1
The symptom of vomiting is pathognomonic of motion sickness under the
conditions of the test, and as such receives the maximum number of points.
On the other end of the motion sickness spectrum, very minor symptoms of
motion sickness are listed in this diagnostic scale as Additional Qualifying
Symptoms (AQS). Included in this symptom category are (a) increased body
temperature (TMP), (b) dizziness/vertigo (DIZ), and (c) headache (HAC). The
subject has the option of reporting two levels of increased temperature and
dizziness (mild-moderate "I" or moderate-severe "II"). Level of headache is
not differentiated with respect to point value. Remaining symptoms of motion
sickness (not including nausea) are (a) drowsiness (DRZ), (b) sweating (SWT),
(c) facial pallor (PAL), and (d) increased salivation (SAL). Each of these
symptoms can be described as mild, moderate or severe by writing in the
appropriately marked box, "I", "II" or "III", respectively. Symptoms of nausea
or any sensations associated with the "gut" can be reported as five separate
levels: (a) epigastric awareness (EA), which is described as increased
sensations in the stomach but not considered uncomfortable; (b) epigastric
discomfort (ED), which is described as NOT nausea, but becoming uncomfortable
(e.g., lump in throat, knot in stomach); and (c) nausea (NSA) , reported as
mild, moderate or severe by entering "I", "II" or "III", respectively.
Results
Tie duration in minutes of motion sickness stimulation tolerated by each
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participant was used as a measure of motion sickness susceptibility. Fig. 1
shows that there was a wide range of motion sickness susceptibilities. The
median test length was 19.5 min., with a range of 3 to 55 min.
Fig. 1
A one-way ANOVA revealed that the final motion sickness scale scores were
larger than the initial scores, £(1, 122) = 526.02, indicating that subjects
did indeed become more motion sick across the test (all ANOVA effects,
correlations and differences between means reported in this paper are
statistically significant at £ < .05). The concluding scale score for 94.5%
of the participants was at or above 8 points, the criterion for severe
malaise; thus, subjects did comply with our request to ride until their motion
sickness was at a high level. The participants were divided into three
approximately equal-sized susceptibility groups based on how many minutes of
motion sickness stimulation they tolerated. The characteristics of these
groups are shown in Table 2. The initial motion sickness scale scores differed
between groups, £(2,124) = 31.52, providing objective evidence that more
highly susceptible subjects became motion sick earlier in the test. There was
no difference between groups on the final scale scores, indicating that the
different susceptibility groups rode to similar motion sickness endpoints.
Table 2
The role of ANS responses in motion sickness was examined in two
complementary sets of analyses which explored: (a) the time course of ANS
.changes across the motion sickness test; and (b) multiple correlations between
ANS responses as predictor variables, with motion sickness scale scores and
minutes of rotation tolerated as criterion variables. The results of these
analyses are .presented in separate sections below.
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ANS changes across the motion sickness test.
For each participant, 1-min. means were computed for HR, BSR, PV, and RR
across the following stages of the motion sickness test: (a) the 5 minutes
immediately preceding rotation (Pretest), (b) the first 5 minutes of rotation
(Start), (c) the last 5 minutes of rotation (Finish), during at least part of
which the subject was assumed to be motion sick, and (d) the 5 minutes
immediately following the termination of rotation (Posttest). The data for
four participants who tolerated only three minutes of rotation were excluded
from these analyses. The means are shown in Figures 2-5 for Stages (Pretest,
Start, Finish, Posttest) X Minutes (1-5 within Stages) X Susceptibility Group
(Low, Moderate, High).
Figs 2-5
For each ANS variable, a preliminary ANOVA was conducted to assess the
effects of test stages. Then, three sets of ANOVAs were conducted to examine
the time course of changes for each ANS variable: (a) Susceptibility (3) X
Minutes (5) within each of the four stages, (b) Susceptibility (3) X Minutes
(2) for the two minutes immediately before and after the onset of rotation,
and (c) Susceptibility (3) X Minutes (2) for the two minutes immediately
before and after rotation ceased.
Visual inspection of Figures 2-5 reveals that all four ANS measures
respond to motion sickness stimulation, and that there is some ANS recovery
when stimulation stops. In the preliminary ANOVA, there was an effect for
.Stages for every ANS variable. Tests of significance between each possible
pair of Stages were conducted using the Fischer Test at £ < .05 (Keppel,
1982, p. 157). The results of these comparisons are listed in Table 3.
Table 3
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The results of the second and third sets of ANOVAs are described below
for each ANS response.
Heart rate. HR drifted upward slightly across the minutes of pretest
from 69.9 beats/min in the first minute to 71.1 beats/min in the fifth, £(4,
496) = 6.06. In pretest there was a Minutes X Susceptibility effect, £(8,
496) = 3.22, apparently caused by an anticipatory increase in HR for the low
susceptibility group at the end of the segment. The onset of rotation was
accompanied by an average increase in HR of 5.5 beats/min, £(1, 124) = 59.21,
that did not interact with Susceptibility. Following the more or less uniform
increase in HR at the onset of rotation, HR continued to rise for the high
susceptible participants while it stabilized for those who were less
susceptible, resulting in a Minutes X Susceptibility interaction, £(8, 496) =
8.55. Heart rate increased significantly across the first five minutes of
rotation for the high susceptibles, but did not change significantly for the
other two groups. A posthoc ANOVA showed that the three groups had different
heart rate responses that occurred as early as the first two minutes of
rotation, £(2, 124) = 9.90. There was an increase in HR of 4.1 beats/min
across the final five minutes of rotation, £(4, 496) = 16.06, with no
differences between groups on this effect. When rotation stopped, there was
immediate HR recovery, reflected in an average HR decrease of 4.2 beats/min in
the first minute of posttest, £(1, 124) = 29.65. There was a Minutes X
Susceptibility effect within the posttest segment for HR, £(8, 496) = 3.23.
.The more susceptible the participant had been to motion sickness stimulation
the greater the HR decrease once rotation ceased, £(8, 496) = 3.23. Across
the five minutes of recovery, HR decreased by an average of 11.9, 10.7, and
5.3 beats/min for the high, moderate, and low susceptibles, respectively.
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Since the high, moderate and low susceptiblity groups rode progressively
longer, the different HR responses of these groups across rotation is
minimized in Figure 3. Perhaps a more revealing analysis is to take the HR
change over the total period of rotation and divide by the duration of
rotation to express the HR change per minute of stimulation. HR for the high
susceptibles accelerated at a rate of 1.14 beats/min across the test, the
moderate susceptibles at 0.44, and the low susceptibles at 0.06. Thus, during
motion sickness stimulation, the HR of high susceptibles accelerated about
19 times as fast as the HR of the low susceptibles.
In summary, HR responded vigorously to motion sickness stimulation. The
overall magnitude of the HR response was related to motion sickness
susceptibility, with those who were more susceptible showing greater changes
in HR, even within the first two minutes. When rotation stopped HR returned
quickly to pretest levels.
Basal skin resistance. The substantial mean differences in BSR between
groups shown in Figure 3 are not statistically significant because of
pronounced individual differences within the groups. BSR changed across
minutes during the pretest, F_(4, 496) = 4.62. After drifting upward by a mean
of 14 Kohms across the first several minutes of the pretest segment, there was
a decrease of about 26 Kohms, apparently in anticipation of rotation, £(4,
496) = 4.62. The onset of rotation resulted in an immediate mean 131 Kohm drop
in BSR, £(1, 124) = 54.98. There was adaptation over the first five minutes
of rotation, with a mean 40 Kohm increase in BSR, £(4, 496) = 7.59. BSR
decreased across the final five minutes of rotation, £(4, 496) = 5.98. This
effect interacted with Susceptibility, £(8, 496) = 2.37. There was a
significant decrease in BSR only for the high susceptibles, who showed an
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average decrease of of 41 Kohms, as compared to the moderate and low
susceptibles, who decreased only 7 and 4 Kohms, respectively. There was no
immediate change in BSR in the first minute of posttest, £ < 1, but there was
an average increase of 41 Kohms across the five minutes of posttest, £(4,
496) = 11.67, reflecting some BSR recovery.
In summary, BSR decreased during motion sickness stimulation, and then
recovered afterward. Those who were highly susceptible to motion sickness
experienced a decrease in BSR as they became sick. Basal skin resistance did
not recover to pretest levels within five minutes after the termination of
rotation.
Pulse volume. As in the case of BSR, there was no significant group
effect on differences in PV during the pretest segment. Pulse volume decreased
from 54.0 to 49.4 arbitrary units across the pretest baseline, £(4, 496) =
5.21, with an apparent anticipatory decrease near the end of the segment. The
onset of rotation prompted an abrupt decrease in PV of 12.5 arbitrary units,
£(1, 124) = 54.42, that did not vary with susceptibility. Pulse volume
recovered somewhat across the first five minutes of rotation, with a mean
increase of 3.4 units, £(4, 495) = 6.78. There was a Minutes X Susceptibility
interaction at the end of rotation, £(8, 496) = 2.11. Pulse volume decreased
significantly across this time period only for the high susceptibles, who
showed a mean drop in PV of 6.3 units. During the first minute after rotation
stopped, PV recovered an average of 8.0 units, £(1, 124) = 31.10. There was a
change in PV across the minutes of the posttest, £(4, 496) = 12.83. Pulse
volume increased significantly by an average of 6.6 units from the first to
third minutes of posttest, then decreased significantly by an average of 3.3
units from the third to the fifth minutes.
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In summary, following an abrupt drop in PV at the onset of rotation, PV
gradually increased as motion sickness stimulation continued. The most
susceptible participants experienced decreased PV as motion sickness
developed. There was a rebound increase in PV when rotation stopped, followed
shortly by a decrease.
Respiration rate. Respiration rate did not change significantly across
the pretest segment. When rotation commenced, RR increased in the first minute
by 3.2 breaths/min, £(!/ 124) = 117.60. This initial RR response to rotation
was followed by partial recovery across the remainder of the first five
minutes of rotation £ (4, 496) = 8.40. Respiration rate changed across the
final five minutes of rotation, £(4, 496)= 2.73. After decreasing an average
of 0.5 breaths/min from the first to the third minutes, RR increased by 0.9
breaths/min across the remaining two minutes of the test. When rotation ended,
there was an average drop in RR of 0.7 breaths/min, £(1, 124) = 6.69.
Recovery continued across the five minutes of posttest, with a mean decrease
of 1.9 breaths/min from the first to the fifth minute, £(4, 496) = 7.79. None
of the significant effects for RR interacted with Susceptibility.
In summary, RR increased with the onset of rotation, recovered as
rotation continued, and then increased across the several minutes leading to
termination. Respiration rate decreased to pretest levels in the five minutes
following the end of rotation.
ANS responses as predictors of motion sickness.
The results presented thus far suggest that certain ANS responses found
early in the motion sickness test may herald the subsequent global
psychophysiological response to motion sickness stimulation. Therefore, in
order to determine which ANS variables might best predict motion sickness
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susceptibility, analyses were undertaken in which all ANS variables were
entered into a predictive model with the minutes of rotation tolerated, and
motion sickness scale scores as the criterion variables.
Two sets of stepwise multiple regression analyses were conducted. The
ANS variables were entered into the regression equations in descending order
of their correlations with the dependent variable, corrected for the effects
of any independent variables that had already been entered. The criterion to
enter an independent variable was £(2,124) of at least 4.0, which
corresponded to a correlation of about .17.
In the first analysis, the 16 predictor variables were the Pretest mean,
change from the last minute of Pretest to the first minute of rotation, change
from the first to the fifth minute of rotation, and change across the last
five minutes of rotation for HR, BSR, PV, and RR. The dependent variable was
the minutes of rotation tolerated. Two ANS variables had adequate predictive
value to enter the multiple regression equation: (a) HR change across the
first five minutes of rotation, £(125) = -.35—the greater the HR increase,
the fewer minutes of rotation tolerated; and (b) HR response to the first
minute of rotation, _r_(125) = -.23— again, the greater the HR increase, the
fewer minutes of rotation tolerated. Thus, the greater the HR response to
rotation, in the first minute or across the first five minutes, the greater
the susceptibility to motion sickness stimulation. The multiple £ between
these variables and minutes of rotation was .42.
In a second approach, the ANS measures for the final five minutes of
rotation were deleted and multiple regression was conducted with the first
diagnostic score as the dependent variable, since this score distinguished
between susceptibility groups as mentioned earlier. The results were similar
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to those for test length. The variables entering the equation, in order, were
(a) HR change across the first five minutes of rotation, _r(125) = .35, and
(b) HR response to the first minute of rotation, r_(125) = .37. In both cases,
the greater the HR acceleration, the more motion sickness reflected in the
scale score. The multiple-^ between the two predictors and the initial motion
sickness scale score was .49.
In summary, the initial HR response to rotation predicted eventual motion
sickness as measured both by the diagnostic motion sickness scale and by how
much motion sickness stimulation the participant was able to tolerate.
Discussion
It is clear from these analyses that autonomic responses do change as
a function of motion sickness stimulation. The lack of autonomic disturbance
observed by Graybiel & Lackner (1980) during sudden-stop motion sickness
tests can only be attributed to the types of measures taken and the manner in
which these measurements were obtained. As can be seen from Figures 2-5,
physiological response levels change rapidly and dramatically at the onset
of stimulation and when the test concludes. Measures of oral temperature,
blood pressure and pulse rate, taken in a 30 second period immediately before
and after motion sickness tests, would not necessarily reflect these changes.
Pulse rate alone could, in fact, produce widely different values if two
measurements were taken only seconds apart during the recovery period.
The inconsistency in ANS responses to motion sickness reviewed by
Money (1970) might be explained as the result of several well-known principles
of psychophysiology, relating to the sources of variability in physiological
activity. As in Graybiel & Lackner's study, the data Money reviewed also
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were influenced by differences in timing of the measurements relative to
stimulus onset. But even if this methodological precaution were taken, the
experimenters would probably still see a certain amount of inconsistency in
their data. First, there is the principle of individual-response stereotypy:
some individuals exhibit maximal ANS responses in one or more organ systens
while showing no significant changes in the activity of other systems. Second,
the principles of autonomic balance, law of initial values, and
(parasympathetic) rebound may explain why some subjects exhibit increases in
the activity levels of specific physiological functions while other subjects
show (paradoxical) decreases in activity. Third, there is the principle of
stimulus-response specificity: the response variability observed within
subjects exposed to different types and durations of motion stimuli. These
sources of response variability were not controlled in the studies reviewed by "
Money.
The final set of analyses performed in this paper describe the value of
examining autonomic behavior as predictors of motion sickness
susceptibility. Although early changes in heart rate were clearly the most
consistent predictors, the reader is cautioned against drawing the
conclusion that heart rate alone is a sufficient descriptor of ANS
i
involvement in motion sickness. It may well be that the most valuable
information on ANS components of motion sickness will be yielded by additional
analyses of this data base, examining types of individual response patterns.
Analyses of individual differences, however, are beyond the scope of the
present paper. We have examined the data of a large sample of people, all
given the same motion sickness test (Coriolis acceleration), in order to
describe the general trend amonc, all subjects. These analyses have produced
PAGE 21
evidence which may elucidate the role of ANS activity in the motion sickness
syndrome.
Our results are in agreement with the findings of Tang & Gernandt (1978)
that sympathetic-like activity is characteristic of ANS responses to
vestibular stimulation. All of the ANS variables described in this paper show
sympathetic activation in the transition from pretest baseline to start of
rotation. These findings also confirm Parker's (1964, 1971) use of amplitude
of the electrodermal response to predict motion sickness susceptibility. The
sympathetic activation associated with motion sickness as demonstrated in
these studies and in this paper indicates that motion sickness can be
categorized as a stress response. In the future, it might be valuable to
compare autonomic responses to other environmental stressors (e.g.,
cold-pressor) to those of motion sickness.
If motion sickness is characterized by sympathetic activation of the
ANS, how can we account for inconsistent, yet beneficial results that are
obtained from anti-motion sickness drugs? As described by Kohl & Homick
(1983), the action of one widely tested drug, Scopalomine, is to block
cholinergic transmitters. They emphasize the contribution of cholinergic
>
descending limbic pathways to motion sickness, and it may be that Scopalomine
i
blocks these central pathways rather than affecting peripheral parasympathetic
activity. Another possible answer to this puzzle might be gained by examining
the time-course of ANS changes observed throughout the motion sickness tests.
Initially, all responses show sympathetic activation. In most cases, this
activation is exaggerated or sustained throughout the end of the test, and is
followed by a profound "rebound" phenomenon during the posttest recovery.
This observation of parasympathetic rebound may hold the key: it may be that
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the nausea and vomiting associated with motion sickness are components of a
large-magnitude parasympathetic reaction to sustained sympathetic activity. If
that were the case, parasympatholytic drugs could result in diminished
symptomatology by effectively reducing the magnitude of this rebound.
Therefore, observations of the beneficial effects of such drugs are not really
inconsistent with our own findings on autonomic responses to motion sickness.
In fact, the behavioral treatment used by our laboratory (AFT) and
parasympatholytic anti-motion sickness drugs may be viewed as being maximally
effective during different time-courses in the development of the motion
sickness syndrome. Autogenic feedback training may effectively reduce
sympathetic tone, thereby preventing the occurence (or likelihood) of the
parasympathetic rebound, while parasympatholytics are effective only when
rebound is imminent, or on-going.
Our use of the present ANS measures does not imply that these are the best
indicators of ANS involvement in motion sickness. Further research using a
variety of other ANS measures, such as the electrogastrogram, impedance
cardiography and blood pressure, will be necessary to ascertain which
variables provide the most comprehensive information on ANS involvement, its
interaction with motion sickness susceptibility, and the propensity for
learned control.
To conclude, we have demonstrated profound autonomic nervous system
changes in association with ground-based motion sickness. The time course and
magnitude of changes in certain of the ANS variables measured differ as a
function of motion sickness susceptibility, and the heart rate measure appears
to predict motion sickness susceptibility within the first two minutes of the
motion sickness test. These findings support our use of AFT in the treatment
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of motion sickness symptomatology, and may lead to a more comprehensive
understanding of physiological mechanisms underlying motion sickness.
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Table 1
Sample Motion Sickness score sheet
DIAGNOSTIC CRITERIA SCALE - MOTION SICKNESS
MALAISE LEVEL POINTS VMT TMP DIZ HAC DRZ SWT PAL SAL NSA ED EA
PATHOGNOMIC 16 I
MAJOR 8 III III III III II,III
MINOR 4 II II II II I
MINIMAL 2 I I I I I
AQS 1 I,II I,II I I
Levels of Severity Identified by Total Points Scored
FRANK SICKNESS SEVERE MALAISE MODERATE-A MODERATE-B SLIGHT MALAISE
(S) (Mill) (MIIA) (MIIB) (MI)
16 points 8-15 points 5-7 points 3-4 points 1-2 points
SYMPTOMS OBSERVED TOTAL
RPM | VMT | TMP | DIZ | HAC | DRZ | SWT | PAL | SAL | NSA I ED I EA | POINTS
I I I I I I I I I I I I
. I I I I I I I I I I I I
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Table 2
Group Assignment By jjiitial Susceptibility To Motion Sickness
Susceptibility N= Mean Test Duration
in Minutes
HIGH 46
MODERATE 43
LOW 38
9.7
18.1
32.9
Mean Diagnostic Score
Start Finish
5.7
2.3
1.2
12.6
13.3
12.1
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Table 3
Significant Differences Between Stages, All ANS Responses
Stage
Stage Pretest Start Finish Posttest
Pretest — HR,BSR,PV,RR HR,BSR,PV,RR HR,BSR
Start — HR,BSR RR,PV
Finish — HR,PV
Posttest —
Note: Significance tested by Fischer Test at £ < .05
(Keppel, 1982, p.157)
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FIGURE CAPTIONS
Figure L. Frequency distribution of minutes of rotation tolerated by
subjects during motion sickness tests.
Figure 2. Mean heart rate, for subject groups divided according to motion
sickness susceptibility, across four time blocks of the motion sickness test:
prestest baseline, first five minutes of the test, last five minutes of the
test, post-test recovery.
Figure 3. Mean basal skin resistance, for subject groups divided according
to motion sickness susceptibility, across four time blocks of the motion
sickness test: pretest baseline, first five minutes of the test, last five
minutes of the test, post-test recovery.
Figure 4. Mean finger pulse volume (in arbitrary units), for subjects
divided according to motion sickness susceptibility, across four time blocks
of the motion sickness test: pretest baseline, first five minutes of the test,
last five minutes of the test, post-test recovery.
Figure 5^ Mean respiratory rate, for subject groups divided according to
motion sickness susceptibility, across four time blocks of the motion sickness
test: pretest baseline, first five minutes of the test, last five minutes of
the test, post-test recovery.
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